Dmitry Balyasny’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Dmitry Balyasny's AQST Position: Q3 2026 in Review
Dmitry Balyasny sold out of Aquestive Therapeutics (AQST) in Q3 2026, closing a stake of 744,536 shares — an estimated $3.1M sold.
Dmitry Balyasny first reported a position in AQST in Q3 2021 and held it in 5 quarters. The position peaked at $12M in Q1 2026. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Dmitry Balyasny reported no remaining Aquestive Therapeutics position as of Q3 2026 after selling out during the quarter.
- Dmitry Balyasny sold 744,536 Aquestive Therapeutics shares in Q3 2026, an estimated $3.1M.
- Dmitry Balyasny first reported a position in Aquestive Therapeutics in Q3 2021 and held it in 5 quarters.
- Dmitry Balyasny's Aquestive Therapeutics position peaked at $12M in Q1 2026.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.